DeepRad.AI
DeepRad.AI
Leverages advanced AI and medical imaging technologies to enhance early detection and prevention for common diseases.
Pre A
Fundraising Target: $2M USD (Domestic)
Schedule:
Current Round – Target Close: March 2025
Next Round – Expected Start: September 2025
2025 Target: $800,000 USD
Coreline
Riverain
V5 Technologies
Company Details
DeepRad.AI is an AI-driven medical device software (SaMD) company founded in 2023, led by experienced radiologists and AI engineers. Our mission is to reshape radiology through AI and promote innovative applications of medical imaging to advance the entire healthcare ecosystem.
DeepLung-CAC: AI-powered Lung Cancer Screening Platform ; DeepBrain-Cognito: AI-powered cognitive screening platform
US Objective
Connect with potential partners
Connect with VCs and angels
Establish local connections
Chia-Hsing Yeh
Business Development Manager (North America)
Yao Chi Chang
CEO
Media Exposure